全球体外膜氧合（体外膜氧合）插管市场规模、份额、趋势和成长分析报告（2026-2034）

预计体外膜氧合（ECMO）插管市场将从 2025 年的 4,036 万美元成长到 2034 年的 6,256 万美元，2026 年至 2034 年的复合年增长率为 4.99%。

随着体外膜氧合（ECMO）疗法在治疗严重心臟衰竭衰竭的重要性日益凸显，全球ECMO插管市场正稳定成长。 ECMO插管是体外生命维持过程中用于体外循环血液的关键组件。急性呼吸窘迫症候群和严重心臟併发症等严重的日益增多，推动了对ECMO系统及相关组件的需求。

重症监护技术的进步和体外膜氧合（ECMO）手术流程的改进也推动了市场成长。现代ECMO插管的设计旨在最大限度地提高血流效率，同时最大限度地减少治疗过程中的併发症。医院和专科加护病房越来越多地采用ECMO系统来处理复杂病例。此外，医护人员对ECMO的认识与训练的提高也提高了ECMO治疗的成功率。

随着医疗系统加大对先进生命支持技术的投入，市场预计将会成长。体外膜氧合（ECMO）设备的研究和创新将带来改进的插管设计和更安全的治疗流程。随着全球重症监护基础设施的扩展和对先进呼吸支援需求的增长，ECMO插管仍将是挽救生命治疗的重要组成部分。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球体外膜氧合（ECMO）插管市场：依类型划分

• 市场分析、洞察与预测
• 静脉-动脉型
• 静脉-静脉
• 动静脉型

第五章 全球体外膜氧合（ECMO）插管市场：依病患类型划分

• 市场分析、洞察与预测
• 新生
• 儿童
• 成人

第六章 全球体外膜氧合插管市场：依应用划分

• 市场分析、洞察与预测
• 呼吸系统
• 心
• ECPR

第七章 全球体外膜氧合（ECMO）插管市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 其他的

第八章 全球体外膜氧合（ECMO）插管市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Medtronic
  • LivaNova PLC
  • Edwards Lifesciences Corporation
  • Getinge
  • Andocor
  • Changzhou KangXin Medical Instruments Co. Ltd
  • Free Life Medical GmbH
  • Fresenius Medical Care AG
  • Abbott

The Extracorporeal Membrane Oxygenation Cannula Market size is expected to reach USD 62.56 Million in 2034 from USD 40.36 Million (2025) growing at a CAGR of 4.99% during 2026-2034.

The global extracorporeal membrane oxygenation cannula market is growing steadily as ECMO therapy becomes increasingly important in the treatment of severe cardiac and respiratory failure. ECMO cannulas are essential components used to circulate blood outside the body during extracorporeal life support procedures. The rising prevalence of critical conditions such as acute respiratory distress syndrome and severe cardiac complications is driving demand for ECMO systems and associated components.

Advancements in critical care technologies and improvements in ECMO procedures are also supporting market growth. Modern ECMO cannulas are designed to enhance blood flow efficiency while minimizing complications during treatment. Hospitals and specialized intensive care units are increasingly adopting ECMO systems to manage complex medical cases. Additionally, increased awareness and training among healthcare professionals are improving the success rates of ECMO therapy.

In the future, the market is expected to grow as healthcare systems invest in advanced life-support technologies. Research and innovation in ECMO equipment will lead to improved cannula designs and safer treatment procedures. As critical care infrastructure expands globally and the demand for advanced respiratory support increases, ECMO cannulas will remain an essential component of life-saving therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Veno-Arterial
• Veno-Venous
• Arterio-Venous

By Patient Type

• Neonates
• Pediatric
• Adult

By Application

• Respiratory
• Cardiac
• ECPR

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Medtronic, LivaNova PLC, Edwards Lifesciences Corporation, Getinge, Andocor, Changzhou KangXin Medical Instruments Co Ltd, Free Life Medical GmbH, Fresenius Medical Care AG, Abbott
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Veno-Arterial Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Veno-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Arterio-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY PATIENT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Patient Type
• 5.2. Neonates Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiac Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. ECPR Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Patient Type
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Patient Type
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Patient Type
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Patient Type
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Patient Type
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Medtronic
  • 10.2.2 LivaNova PLC
  • 10.2.3 Edwards Lifesciences Corporation
  • 10.2.4 Getinge
  • 10.2.5 Andocor
  • 10.2.6 Changzhou KangXin Medical Instruments Co. Ltd
  • 10.2.7 Free Life Medical GmbH
  • 10.2.8 Fresenius Medical Care AG
  • 10.2.9 Abbott